Clinical Trial Update: The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS [Phase 4]

View source ↗

Summary

Phase 4 trial update for Study PLUS aimed at reducing systemic lupus erythematosus flares. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED